Publication: 2106

Association study of the let-7 miRNA-complementary site variant in the 3’ untranslated region of the KRAS gene in stage III colon cancer (NCCTG N0147 clinical trial)
      QxMD      Google Scholar   
Citation:
Clin Cancer Res vol 20 (12) 3319-3327
Year:
2014
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
3
Parents:
337  
Children:
None
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
   
Pharmas:
 
Grants:
CA37377, CA449957, CA33601, K05CA-142885, N01 CA032102, CA35103, U10 CA021115, U10 CA012027, CA12027, U10 CA031946, U10 CA033601, U10 CA037404, U24 CA114740, U10 CA014028, CA14028, N01 CA063844, CA-35113, CA-32102, U10 CA032102, U10 CA035113, P30 CA015083, CA- 114740, CA-3527 2, CA25224, K05 CA142885, CA21115, U10 CA025224, CA31946, U10 CA063844, CA37404, U10 CA037377, U10 CA035103  
Corr. Author:
 
Authors:
               
Networks:
 
Study
NCCTG-N0147
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
KRAS-LCS6 genotype, let-7, microRNA, colon cancer, single nucleotide polymorphism